GRCE
NASDAQ · Pharmaceuticals
Grace Therapeutics Inc
$2.11
+0.01 (+0.48%)
Open$2.10
Previous Close$2.10
Day High$2.13
Day Low$2.08
52W High$5.18
52W Low$1.79
Volume—
Avg Volume209.9K
Market Cap44.39M
P/E Ratio—
EPS$-1.18
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+994.3% upside
Current
$2.11
$2.11
Target
$23.09
$23.09
$18.68
$23.09 avg
$33.94
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 19.56M | 18.44M | 15.17M |
| Net Income | 2.85M | 2.16M | 2.15M |
| Profit Margin | 14.6% | 11.7% | 14.2% |
| EBITDA | 5.50M | 5.11M | 4.77M |
| Free Cash Flow | 2.45M | 3.17M | 1.86M |
| Rev Growth | +16.3% | +19.0% | +18.1% |
| Debt/Equity | 0.50 | 0.57 | 0.59 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |